【摘 要】
：
Peripheral arterial disease (PAD) represents a worldwide cause of mortality and morbidity which is frequently underrecognized and undertreated.Given the global ascent of atherosclerotic cardiovascular
【机 构】
：
Interventional Cardiologist Heart and Vascular Consultants USA
【出 处】
：
BITs 2rd Annual World Cancer Congress of Cardiology-2010(201
论文部分内容阅读
Peripheral arterial disease (PAD) represents a worldwide cause of mortality and morbidity which is frequently underrecognized and undertreated.Given the global ascent of atherosclerotic cardiovascular disease as a cause of significant mortality and morbidity, new approaches to treatment are warranted.With the accelerated advances in new technology, endovascular treatment methods for these conditions gain more acceptance, given their minimally invasive character and improved performance.At the same time, significant challenges have arisen, given anatomic complexity and variable pathophysiologic manifestations in different arterial territories.The current presentation will focus on endovascular approaches to treatment, and especially new methods and novel devices for treating challenging arterial beds, among others the superficial femoral artery (SFA), renal arteries and potential new therapeutic applications in the management of resistant arterial hypertension.
其他文献
Background: In the treatment of bifurcation lesions, routine stenting of both branches has thus far failed to demonstrate a clear clinical advantage over a provisional one-stent strategy.On the other
Objectives: To study the relationships between total stent length (TSL) and long term clinical outcomes after Sirolimus eluting stent (SES) implantation.Background: SES compared to bare-metal stent us
Transradial vascular access provides several advantages with respect to transfcmoral access in terms of patients comfort, nurse workload, early patient mobilization and, most importantly, vascular acc
Introduction: Aortic stenosis (AS) causes angina despite unobstructed arteries.Measurement of conventional coronary hemodynamic parameters in patients undergoing valvular surgery has failed to explain
Aim: To assess the intermediate and long term outcome of different type device closure of PFO and ASD.Between 1997 and 2010, 403 patients (95 with PFO and 308 with ASD) underwent pcrcutaneous closure
Objective: Hemothorax is an old malady with clear guidelines of management.However, bleeding located into the chest but outside the parietal pleura recently termed extrapleural hematoma1 still poses c
Introduction: Destination therapy (DT) using mechanical circulatory support (MCS) has been an accepted option for patients in class Ⅳ heart failure who are otherwise not candidates for a cardiac trans
Interventional Cardiology for the treatment of coronary artery disease (CAD) has been marked by thirty productive years of technological advancements.These advancements have included (in succession) a
This presentation discusses two novel areas of cardiovascular therapy: endoscopic cardiac surgery and suction thrombectomy.Endoscopic visualization has been applied to traditional open cardiac surgica
To improve the drawback points of conventional and commercially available medical adhesives, such as cyanoacrylate, aldehyde-based, and fibrin glue, new type bioadhesive has been prepared using medica